Repurposing Tyrosine Kinase Inhibitors to Overcome Multidrug
Resistance in Cancer: A Focus on Transporters and Lysosomal
Sequestration

J 2020

Repurposing Tyrosine Kinase Inhibitors to Overcome Multidrug Resistance in Cancer: A Focus on Transporters and Lysosomal Sequestration

KRCHNIAKOVÁ, Mária, Jan ŠKODA, Jakub NERADIL, Petr CHLAPEK, Renata VESELSKÁ et. al.

Základní údaje

Originální název

Repurposing Tyrosine Kinase Inhibitors to Overcome Multidrug Resistance in Cancer: A Focus on Transporters and Lysosomal Sequestration

Autoři

KRCHNIAKOVÁ, Mária (703 Slovensko, domácí), Jan ŠKODA (203 Česká republika, domácí), Jakub NERADIL (203 Česká republika, domácí), Petr CHLAPEK (203 Česká republika, domácí) a Renata VESELSKÁ (203 Česká republika, garant, domácí)

Vydání

International Journal of Molecular Sciences, Basel, MDPI, 2020, 1422-0067

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

10608 Biochemistry and molecular biology

Stát vydavatele

Švýcarsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 5.923

Kód RIV

RIV/00216224:14310/20:00118624

Organizační jednotka

Přírodovědecká fakulta

DOI

http://dx.doi.org/10.3390/ijms21093157

UT WoS

000535581700128

Klíčová slova anglicky

tyrosine kinase inhibitor; multidrug resistance; cancer; ABC transporter; SLC transporter; lysosomal sequestration

Štítky

rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 31. 8. 2021 16:29, Mgr. Marie Šípková, DiS.

Anotace

V originále

Tyrosine kinase inhibitors (TKIs) are being increasingly used to treat various malignancies. Although they were designed to target aberrant tyrosine kinases, they are also intimately linked with the mechanisms of multidrug resistance (MDR) in cancer cells. MDR-related solute carrier (SLC) and ATB-binding cassette (ABC) transporters are responsible for TKI uptake and efflux, respectively. However, the role of TKIs appears to be dual because they can act as substrates and/or inhibitors of these transporters. In addition, several TKIs have been identified to be sequestered into lysosomes either due to their physiochemical properties or via ABC transporters expressed on the lysosomal membrane. Since the development of MDR represents a great concern in anticancer treatment, it is important to elucidate the interactions of TKIs with MDR-related transporters as well as to improve the properties that would prevent TKIs from diffusing into lysosomes. These findings not only help to avoid MDR, but also help to define the possible impact of combining TKIs with other anticancer drugs, leading to more efficient therapy and fewer adverse effects in patients.

Návaznosti

NV17-33104A, projekt VaV

Název: Terapeutický potenciál nových thiosemicarbazonů v dětské onkologii: možnosti překonání Pgp-zprostředkované lékové rezistence

Citovat

KRCHNIAKOVÁ, Mária, Jan ŠKODA, Jakub NERADIL, Petr CHLAPEK a Renata VESELSKÁ. Repurposing Tyrosine Kinase Inhibitors to Overcome Multidrug Resistance in Cancer: A Focus on Transporters and Lysosomal Sequestration. International Journal of Molecular Sciences. Basel: MDPI, 2020, roč. 21, č. 9, s. 1-19. ISSN 1422-0067. Dostupné z: https://dx.doi.org/10.3390/ijms21093157.

@article{1689863,
   author = {Krchniaková, Mária and Škoda, Jan and Neradil, Jakub and Chlapek, Petr and Veselská, Renata},
   article_location = {Basel},
   article_number = {9},
   doi = {http://dx.doi.org/10.3390/ijms21093157},
   keywords = {tyrosine kinase inhibitor; multidrug resistance; cancer; ABC transporter; SLC transporter; lysosomal sequestration},
   language = {eng},
   issn = {1422-0067},
   journal = {International Journal of Molecular Sciences},
   title = {Repurposing Tyrosine Kinase Inhibitors to Overcome Multidrug Resistance in Cancer: A Focus on Transporters and Lysosomal Sequestration},
   url = {https://doi.org/10.3390/ijms21093157},
   volume = {21},
   year = {2020}
}

TY  - JOUR
ID  - 1689863
AU  - Krchniaková, Mária - Škoda, Jan - Neradil, Jakub - Chlapek, Petr - Veselská, Renata
PY  - 2020
TI  - Repurposing Tyrosine Kinase Inhibitors to Overcome Multidrug Resistance in Cancer: A Focus on Transporters and Lysosomal Sequestration
JF  - International Journal of Molecular Sciences
VL  - 21
IS  - 9
SP  - 1-19
EP  - 1-19
PB  - MDPI
SN  - 14220067
KW  - tyrosine kinase inhibitor
KW  - multidrug resistance
KW  - cancer
KW  - ABC transporter
KW  - SLC transporter
KW  - lysosomal sequestration
UR  - https://doi.org/10.3390/ijms21093157
L2  - https://doi.org/10.3390/ijms21093157
N2  - Tyrosine kinase inhibitors (TKIs) are being increasingly used to treat various malignancies. Although they were designed to target aberrant tyrosine kinases, they are also intimately linked with the mechanisms of multidrug resistance (MDR) in cancer cells. MDR-related solute carrier (SLC) and ATB-binding cassette (ABC) transporters are responsible for TKI uptake and efflux, respectively. However, the role of TKIs appears to be dual because they can act as substrates and/or inhibitors of these transporters. In addition, several TKIs have been identified to be sequestered into lysosomes either due to their physiochemical properties or via ABC transporters expressed on the lysosomal membrane. Since the development of MDR represents a great concern in anticancer treatment, it is important to elucidate the interactions of TKIs with MDR-related transporters as well as to improve the properties that would prevent TKIs from diffusing into lysosomes. These findings not only help to avoid MDR, but also help to define the possible impact of combining TKIs with other anticancer drugs, leading to more efficient therapy and fewer adverse effects in patients.
ER  -

KRCHNIAKOVÁ, Mária, Jan ŠKODA, Jakub NERADIL, Petr CHLAPEK a Renata VESELSKÁ. Repurposing Tyrosine Kinase Inhibitors to Overcome Multidrug Resistance in Cancer: A Focus on Transporters and Lysosomal Sequestration. \textit{International Journal of Molecular Sciences}. Basel: MDPI, 2020, roč.~21, č.~9, s.~1-19. ISSN~1422-0067. Dostupné z: https://dx.doi.org/10.3390/ijms21093157.

Podrobný výpis o publikaci